Low-dose colchicine for atherosclerosis: long-term safety

Focus on ischaemic heart disease: prevention with colchicine, role of the brain–heart axis, new therapeutic targets for ischaemia–reperfusion injury

F Crea - European Heart Journal, 2024 - academic.oup.com
Art Review article entitled 'Low-dose colchicine for atherosclerosis: long-term safety'by
Stefan Mark Nidorf from the Heart and Vascular Research Institute in Perth, Western …
相关文章 所有 3 个版本

Low-dose colchicine for chronic stable atherosclerosis: Under-appreciated and under-prescribed

PM Ridker - European Journal of Internal Medicine, 2024 - ejinme.com
“LoDoCo 0.5 mg daily” was indicated to “reduce the risk of myocardial infarction, stroke,
coronary revascularization and cardiovascular death in adult patients with established …
相关文章 所有 3 个版本